HPR193 Evaluation of the Reimbursement Status and Market Access of Oncology Medicines in Türkiye: A Descriptive Analysis
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1617
https://www.valueinhealthjournal.com/article/S1098-3015(24)04480-2/fulltext
Title :
HPR193 Evaluation of the Reimbursement Status and Market Access of Oncology Medicines in Türkiye: A Descriptive Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)04480-2&doi=10.1016/j.jval.2024.10.1617
First page :
Section Title :
Open access? :
No
Section Order :
11080